Detalhe da pesquisa
1.
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.
Proc Natl Acad Sci U S A
; 120(49): e2312261120, 2023 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38011568